Psychedelic Researchers Respond to FDA’s Push to Reduce Animal Testing

The FDA is pushing researchers to reduce their use of animal models and instead adopt ‘new approach methodologies’, like organoids and AI modelling. Researchers are divided: while some see this as a chance to innovate, many others are concerned it could compromise safety and disincentivise the use of established models. Here, Dr. Alaina Jaster speaks with psychedelic scientists and drug developers…

Source